Wells Fargo
PRCT icon

Wells Fargo’s Procept Biorobotics PRCT Stock Holding History

Wells Fargo’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33M Buy
147,291
+52,168
+55% +$1.31M ﹤0.01% 3190
2026
Q1 		$2.38M Buy
95,123
+1,262
+1% +$35.6K ﹤0.01% 3136
2025
Q4 		$2.95M Buy
93,861
+24,203
+35% +$803K ﹤0.01% 3133
2025
Q3 		$2.49M Buy
69,658
+3,298
+5% +$151K ﹤0.01% 3169
2025
Q2 		$3.82M Buy
66,360
+8,174
+14% +$462K ﹤0.01% 2681
2025
Q1 		$3.39M Sell
58,186
-2,939
-5% -$201K ﹤0.01% 2717
2024
Q4 		$4.92M Sell
61,125
-11,762
-16% -$1M ﹤0.01% 2457
2024
Q3 		$5.84M Sell
72,887
-2,019
-3% -$143K ﹤0.01% 2232
2024
Q2 		$4.58M Buy
74,906
+36,861
+97% +$2.19M ﹤0.01% 2331
2024
Q1 		$1.88M Buy
38,045
+5,909
+18% +$281K ﹤0.01% 3021
2023
Q4 		$1.35M Sell
32,136
-2,511
-7% -$85.5K ﹤0.01% 3221
2023
Q3 		$1.14M Buy
34,647
+10,530
+44% +$359K ﹤0.01% 3241
2023
Q2 		$853K Buy
24,117
+15,076
+167% +$498K ﹤0.01% 3578
2023
Q1 		$257K Buy
9,041
+8,701
+2,559% +$307K ﹤0.01% 4286
2022
Q4 		$14.1K Sell
340
-174
-34% -$7.47K ﹤0.01% 5414
2022
Q3 		$21K Sell
514
-83
-14% -$3.31K ﹤0.01% 5370
2022
Q2 		$20K Sell
597
-1,008
-63% -$36.7K ﹤0.01% 5452
2022
Q1 		$56K Sell
1,605
-2,684
-63% -$64.6K ﹤0.01% 5600
2021
Q4 		$107K Buy
+4,289
New +$159K ﹤0.01% 5593

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wells Fargo's PRCT Position: Q2 2026 in Review

Wells Fargo increased its Procept Biorobotics (PRCT) stake by 55% in Q2 2026, buying an estimated $1.31M and bringing the position to 147,291 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #3190.

Wells Fargo first reported a position in PRCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.84M in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Wells Fargo held 147,291 shares of Procept Biorobotics worth $3.33M as of Q2 2026.
  • Wells Fargo bought 52,168 Procept Biorobotics shares in Q2 2026, an estimated $1.31M.
  • Procept Biorobotics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3190 holding.
  • Wells Fargo first reported a position in Procept Biorobotics in Q4 2021 and has held it in 19 quarters since.
  • Wells Fargo's Procept Biorobotics position peaked at $5.84M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.